• B-Cell Non-Hodgkin Lymphoma Pipeline 2025: Therapies Under openPR.com Wed, 30 Apr 2025 20:42:00 GMT
• Oncternal Therapeutics (NASDAQ:ONCT) Earns Hold Rating from Analysts at StockNews.com Defense World Mon, 28 Apr 2025 06:32:18 GMT
• stocknews.com initiates coverage on oncternal therapeutics (nasdaq:onct) Defense World Sun, 20 Apr 2025 07:00:00 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated at stocknews.com The AM Reporter Mon, 14 Apr 2025 05:32:45 GMT
• Oncternal Therapeutics (NASDAQ:ONCT) Now Covered by Analysts at StockNews.com Defense World Sat, 12 Apr 2025 07:00:00 GMT
• chronic lymphocytic leukemia pipeline analysis and clinical openPR.com Tue, 08 Apr 2025 07:00:00 GMT
• Oncternal Therapeutics (NASDAQ:ONCT) Coverage Initiated by Analysts at StockNews.com Defense World Fri, 04 Apr 2025 07:00:00 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated by analysts at stocknews.com Defense World Thu, 27 Mar 2025 07:00:00 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated by analysts at stocknews.com The AM Reporter Thu, 20 Mar 2025 07:00:00 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated by analysts at stocknews.com Defense World Wed, 19 Mar 2025 09:25:40 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated by analysts at stocknews.com Defense World Tue, 11 Mar 2025 07:00:00 GMT
• future industry growth of metastatic prostate cancer market openPR.com Mon, 10 Mar 2025 07:00:00 GMT
• Oncternal Therapeutics Announces Intent to Voluntarily Delist from Nasdaq and Deregister with the SEC GlobeNewswire Fri, 07 Mar 2025 08:00:00 GMT
• From Nasdaq to Dark: What's Next for Oncternal After March 2025 Delisting? Stock Titan Fri, 07 Mar 2025 08:00:00 GMT
• b-cell non-hodgkin lymphoma pipeline 2024: moa, roa, and clinical trial insights explored by delveinsight | biegene, oncternal the... Barchart Wed, 05 Mar 2025 21:51:14 GMT
• ewing sarcoma clinical trials and studies: ema, pdma, fda approvals, mechanism of action, roa, nda, ind, and companies The Globe and Mail Mon, 03 Mar 2025 16:31:03 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated by analysts at stocknews.com Defense World Mon, 03 Mar 2025 07:20:23 GMT
• oncternal therapeutics (onct) expected to announce quarterly earnings on thursday Defense World Thu, 27 Feb 2025 08:00:00 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated by analysts at stocknews.com Defense World Sun, 23 Feb 2025 11:14:39 GMT
• marginal zone lymphoma clinical trials and studies: ema, pdma, fda approvals, mechanism of action, roa, nda, ind, and companies The Globe and Mail Wed, 19 Feb 2025 18:56:56 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated by analysts at stocknews.com Defense World Sat, 15 Feb 2025 06:13:01 GMT
• billionaire investor david tepper doubles down on these stocks. should you follow? The Globe and Mail Wed, 12 Feb 2025 08:00:00 GMT
• metastatic prostate cancer clinical and non-clinical studies, openPR Mon, 10 Feb 2025 16:11:00 GMT
• oncternal therapeutics (nasdaq:onct) earns hold rating from analysts at stocknews.com Defense World Mon, 10 Feb 2025 08:00:00 GMT
• head-to-head survey: oncternal therapeutics (nasdaq:onct) & organigram (nasdaq:ogi) Defense World Mon, 03 Feb 2025 06:25:27 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated at stocknews.com Defense World Thu, 30 Jan 2025 08:00:00 GMT
• ONCT stock price: Oncternal stock crashes by 60% after layoffs Markets.com Thu, 23 Jan 2025 08:00:00 GMT
• oncternal therapeutics (nasdaq:onct) earns hold rating from analysts at stocknews.com Defense World Wed, 22 Jan 2025 08:00:00 GMT
• ibm stock 2025 outlook: can ai and cloud revive ibm’s growth? The Globe and Mail Tue, 14 Jan 2025 08:00:00 GMT
• stocknews.com begins coverage on oncternal therapeutics (nasdaq:onct) Defense World Tue, 14 Jan 2025 08:00:00 GMT
• ewing sarcoma clinical trials 2024: ema, pdma, fda approvals, openPR Mon, 06 Jan 2025 08:00:00 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated by analysts at stocknews.com Defense World Mon, 06 Jan 2025 08:00:00 GMT
• oncternal therapeutics (nasdaq:onct) now covered by analysts at stocknews.com Defense World Sun, 29 Dec 2024 07:45:38 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated at stocknews.com Defense World Sat, 21 Dec 2024 08:00:00 GMT
• oncternal therapeutics to participate in the h.c. wainwright 24th annual global investment conference Marketscreener.com Thu, 19 Dec 2024 13:30:01 GMT
• celu - celularity inc. latest stock news & market updates StockTitan Tue, 10 Dec 2024 18:09:48 GMT
• 'fresh-in, fresh-out' dual-targeted car t-cell therapy shows promise in phase ii dlbcl trial Precision Medicine Online Sun, 08 Dec 2024 08:00:00 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated by analysts at stocknews.com Defense World Thu, 05 Dec 2024 08:00:00 GMT
• onct stock touches 52-week low at $0.61 amid market challenges Investing.com Mon, 02 Dec 2024 08:00:00 GMT
• stocknews.com initiates coverage on oncternal therapeutics (nasdaq:onct) Defense World Wed, 27 Nov 2024 09:50:32 GMT
• onct stock touches 52-week low at $0.83 amid market challenges Investing.com Tue, 26 Nov 2024 04:39:51 GMT
• onct stock touches 52-week low at $0.83 amid market challenges Investing.com India Mon, 25 Nov 2024 08:00:00 GMT
• oncternal shares to be delisted from nasdaq by investing.com Investing.com South Africa Mon, 25 Nov 2024 08:00:00 GMT
• onct (oncternal therapeutics) 9-day rsi : 33.20 (as of nov. 20, 2024) GuruFocus.com Wed, 20 Nov 2024 21:14:16 GMT
• stocknews.com initiates coverage on oncternal therapeutics (nasdaq:onct) Defense World Tue, 19 Nov 2024 08:00:00 GMT
• oncternal announces workforce reduction, executive changes Investing.com Sat, 16 Nov 2024 00:04:13 GMT
• oncternal announces workforce reduction, executive changes Investing.com Fri, 15 Nov 2024 08:00:00 GMT
• oncternal therapeutics announces workforce reduction and executive changes TipRanks Thu, 14 Nov 2024 08:00:00 GMT
• onct stock touches 52-week low at $1.03 amid market challenges Investing.com Thu, 14 Nov 2024 06:09:01 GMT
• onct stock touches 52-week low at $1.03 amid market challenges Investing.com Wed, 13 Nov 2024 08:00:00 GMT
• oncternal therapeutics faces workforce reduction challenges: potential risks and implications TipRanks Fri, 08 Nov 2024 06:04:04 GMT
• phase 1/2 trial of onct-534 in mcrpc has been terminated Urology Times Thu, 07 Nov 2024 08:00:00 GMT
• oncternal therapeutics faces workforce reduction challenges: potential risks and implications TipRanks Thu, 07 Nov 2024 08:00:00 GMT
• stocknews.com initiates coverage on oncternal therapeutics (nasdaq:onct) Defense World Sun, 03 Nov 2024 06:13:40 GMT
• oncternal therapeutics, inc. announces updated safety and efficacy data for phase 1/2 study of onct-534 for the treatment of r/r m... Marketscreener.com Wed, 30 Oct 2024 14:27:29 GMT
• oncternal therapeutics announces updated data from phase 1/2 study of onct-534 TipRanks Tue, 22 Oct 2024 13:07:06 GMT
• oncternal reports positive prostate cancer treatment results by investing.com Investing.com UK Tue, 22 Oct 2024 07:00:00 GMT
• oncternal therapeutics announces updated safety and efficacy data for phase 1/2 study of onct-534 for the treatment of r/r metasta... GlobeNewswire Tue, 22 Oct 2024 07:00:00 GMT
• onct-534 reduces psa levels, is tolerable in relapsed/refractory mcrpc OncLive Tue, 22 Oct 2024 07:00:00 GMT
• b-cell non-hodgkin lymphoma pipeline assessment 2024: therapies, clinical trials, and growth prospects | biegene, oncternal therap... Barchart Fri, 18 Oct 2024 07:00:00 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated at stocknews.com Defense World Fri, 18 Oct 2024 06:21:41 GMT
• onct stock touches 52-week low at $1.19 amid market challenges Investing.com Australia Fri, 11 Oct 2024 08:00:34 GMT
• oncternal therapeutics inc (onct) q2 2024 earnings call highligh GuruFocus Wed, 09 Oct 2024 07:00:00 GMT
• onct stock touches 52-week low at $1.19 amid market challenges Investing.com Wed, 09 Oct 2024 07:00:00 GMT
• onct stock touches 52-week low at $1.31 amid market challenges Investing.com Australia Tue, 01 Oct 2024 01:14:24 GMT
• onct stock touches 52-week low at $1.31 amid market challenges Investing.com Mon, 30 Sep 2024 07:00:00 GMT
• recent research analysts’ ratings changes for oncternal therapeutics (onct) Defense World Fri, 27 Sep 2024 07:00:00 GMT
• layoff tracker: bluebird bio to cut 25% of workforce and more news BioSpace Wed, 25 Sep 2024 07:00:00 GMT
• dr. nickols on phase 2 solar trial of multimodal therapy in prostate cancer Urology Times Tue, 24 Sep 2024 07:00:00 GMT
• oncternal therapeutics (nasdaq:onct) now covered by analysts at stocknews.com Defense World Tue, 24 Sep 2024 06:18:11 GMT
• onconetix, inc. announces 1-for-40 reverse stock split and results of the annual meeting of stockholders GlobeNewswire Fri, 20 Sep 2024 15:45:54 GMT
• investors watch key players in oncology as cancer cases set to skyrocket Baystreet.ca Fri, 20 Sep 2024 15:07:58 GMT
• investors who lost money on outset medical, inc. (om) should contact levi & korsinsky about pending class action - om GlobeNewswire Thu, 19 Sep 2024 17:39:48 GMT
• oncolytics biotech (nasdaq:oncy) stock rating reaffirmed by hc wainwright MarketBeat Thu, 19 Sep 2024 16:55:32 GMT
• recent breakthroughs in cancer research could impact these key companies Baystreet.ca Thu, 19 Sep 2024 15:52:14 GMT
• oncolytics biotech® reports favorable results for bracelet-1 breast cancer study reinforcing path to funding of a registration-ena... PR Newswire Thu, 19 Sep 2024 11:00:00 GMT
• is on holding ag's (nyse:onon) recent stock performance tethered to its strong fundamentals? Simply Wall St Thu, 19 Sep 2024 10:26:14 GMT
• on (nyse:onon) given new $59.00 price target at stifel nicolaus Defense World Thu, 19 Sep 2024 08:49:48 GMT
• biopharma layoff tracker 2024: agc biologics, oncternal, biosense webster and more cut staff BioSpace Thu, 19 Sep 2024 07:00:00 GMT
• on (nyse:onon) reaches new 1-year high after analyst upgrade Defense World Thu, 19 Sep 2024 05:08:48 GMT
• on holding ag shares get price target boost, buy rating from stifel Investing.com Wed, 18 Sep 2024 16:16:16 GMT
• investing in on holding ag (onon) is getting more attractive Knox Daily Wed, 18 Sep 2024 14:54:53 GMT
• on (nyse:onon) hits new 1-year high after analyst upgrade MarketBeat Wed, 18 Sep 2024 14:26:48 GMT
• does on holding (nyse:onon) deserve a spot on your watchlist? Yahoo Finance Wed, 18 Sep 2024 10:55:14 GMT
• around the helix: cell and gene therapy company updates – september 18, 2024 CGTLive™ Wed, 18 Sep 2024 07:00:00 GMT
• on holding ag: -0.15% growth from 52-week low, yet analysts divided The InvestChronicle Tue, 17 Sep 2024 20:24:09 GMT
• understanding onon’s financial ratios: a beginner’s guide US Post News Tue, 17 Sep 2024 18:18:30 GMT
• private advisor group llc purchases 7,154 shares of on holding ag (nyse:onon) Defense World Tue, 17 Sep 2024 11:51:12 GMT
• investor’s delight: on holding ag (onon) closes weak at 48.63, down -0.86 The Dwinnex Mon, 16 Sep 2024 18:09:22 GMT
• biopharma layoff tracker 2024: oncternal, biosense webster, charles river laboratories and more cut staff BioSpace Mon, 16 Sep 2024 07:00:00 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated by analysts at stocknews.com Defense World Mon, 16 Sep 2024 06:21:07 GMT
• Oncternal Therapeutics Axes B-Cell Lymphoma Trial for CAR-T Therapy ONCT-808 CGTLive® Sun, 15 Sep 2024 07:00:00 GMT
• oncternal therapeutics (nasdaq:onct) downgraded by northland capmk Defense World Sun, 15 Sep 2024 05:43:36 GMT
• td asset management inc invests $1.52 million in on holding ag (nyse:onon) Defense World Sat, 14 Sep 2024 10:56:55 GMT
• analyzing the impact of earnings reports on oncternal therapeutics inc inc. (onct) price performance The InvestChronicle Fri, 13 Sep 2024 11:50:29 GMT
• in the green: oncternal therapeutics inc (onct) closes at 1.70, up/down -59.09 from previous day The Dwinnex Fri, 13 Sep 2024 11:04:46 GMT
• Oncternal stock crashes by 60% as it lays off staff and scraps trials Clinical Trials Arena Fri, 13 Sep 2024 07:00:00 GMT
• north american morning briefing : stock futures -2- Marketscreener.com Fri, 13 Sep 2024 07:00:00 GMT
• oncternal therapeutics announces workforce reduction and trial discontinuations by investing.com Investing.com Australia Fri, 13 Sep 2024 07:00:00 GMT
• director wills robert james acquire 3,086 shares of oncternal therapeutics inc [onct] Knox Daily Fri, 13 Sep 2024 07:00:00 GMT
• Oncternal folds all clinical trials after lackluster data drop, patient death Fierce Biotech Thu, 12 Sep 2024 07:00:00 GMT
• Oncternal Therapeutics Announces Termination of its Clinical Studies and Exploration of Strategic Alternatives GlobeNewswire Thu, 12 Sep 2024 07:00:00 GMT
• oncternal therapeutics ends development activities, mulls options MarketWatch Thu, 12 Sep 2024 07:00:00 GMT
• oncternal therapeutics cuts jobs, discontinues product development amid business review MarketWatch Thu, 12 Sep 2024 07:00:00 GMT
• oncternal stock plunges on portfolio shakeup (nasdaq:onct) Seeking Alpha Thu, 12 Sep 2024 07:00:00 GMT
• oncternal therapeutics downgraded to market perform from outperform at northland TipRanks Thu, 12 Sep 2024 07:00:00 GMT
• onct stock touches 52-week low at $1.7 amid market challenges Investing.com India Thu, 12 Sep 2024 07:00:00 GMT
• oncternal therapeutics announces workforce reduction and trial discontinuations Investing.com Thu, 12 Sep 2024 07:00:00 GMT
• oncternal halts trials for cancer treatments, seeks alternatives Investing.com Thu, 12 Sep 2024 07:00:00 GMT
• oncternal therapeutics (nasdaq:onct) earns hold rating from analysts at stocknews.com Defense World Sat, 31 Aug 2024 06:16:11 GMT
• oncternal therapeutics (nasdaq:onct) research coverage started at stocknews.com Defense World Fri, 23 Aug 2024 06:43:56 GMT
• onct (oncternal therapeutics) financial strength : 8 (as of jun. 2024) GuruFocus.com Sat, 17 Aug 2024 15:45:18 GMT
• oncternal therapeutics (nasdaq:onct) earns hold rating from analysts at stocknews.com Defense World Thu, 15 Aug 2024 08:03:26 GMT
• oncternal therapeutics (nasdaq:onct) pt lowered to $18.00 at hc wainwright Defense World Mon, 12 Aug 2024 12:35:26 GMT
• oncternal therapeutics second quarter 2024 earnings: beats expectations Yahoo Finance Sun, 11 Aug 2024 13:51:17 GMT
• oncternal therapeutics, inc. (onct) q2 2024 earnings call transcript Seeking Alpha Sat, 10 Aug 2024 05:46:01 GMT
• oncternal therapeutics price target lowered to $18 from $19 at h.c. wainwright TipRanks Fri, 09 Aug 2024 07:00:00 GMT
• onct stock earnings: oncternal therapeutics beats eps, beats revenue for q2 2024 InvestorPlace Fri, 09 Aug 2024 01:09:26 GMT
• oncternal therapeutics (onct) reports q2 loss, tops revenue estimates Yahoo Finance Thu, 08 Aug 2024 21:30:11 GMT
• oncternal therapeutics (nasdaq:onct) stock, analyst ratings, price targets, forecasts Benzinga Thu, 08 Aug 2024 20:08:00 GMT
• oncternal therapeutics provides business update and announces second quarter 2024 financial results Yahoo Finance Thu, 08 Aug 2024 07:00:00 GMT
• oncternal therapeutics: q2 earnings snapshot San Francisco Chronicle Thu, 08 Aug 2024 07:00:00 GMT
• oncternal therapeutics reports q2 eps ($2.89 ), consensus ($3.10) TipRanks Thu, 08 Aug 2024 07:00:00 GMT
• oncternal therapeutics (onct) scheduled to post quarterly earnings on thursday Defense World Wed, 07 Aug 2024 11:52:34 GMT
• oncternal therapeutics (nasdaq:onct) now covered by stocknews.com Defense World Wed, 07 Aug 2024 05:42:37 GMT
• oncternal therapeutics to provide business update and report second quarter 2024 financial results GlobeNewswire Thu, 01 Aug 2024 20:06:26 GMT
• oncternal therapeutics (nasdaq:onct) now covered by stocknews.com Defense World Tue, 30 Jul 2024 07:00:00 GMT
• hc wainwright reiterates buy rating for oncternal therapeutics (nasdaq:onct) Defense World Tue, 16 Jul 2024 22:12:03 GMT
• layoff tracker: relay therapeutics will lay off 10% of employees BioSpace Mon, 15 Jul 2024 11:09:48 GMT
• layoff tracker: j&j, bayer and pfizer to cut nearly 500 combined employees BioSpace Mon, 15 Jul 2024 11:09:48 GMT
• layoff tracker: bluebird bio to cut 25% of workforce and more news BioSpace Mon, 15 Jul 2024 11:09:48 GMT
• layoff tracker: bms layoffs in new jersey continue with 79 cut and more news BioSpace Mon, 15 Jul 2024 11:09:48 GMT
• biopharma layoff tracker 2024: agc biologics, oncternal, biosense webster and more cut staff BioSpace Mon, 15 Jul 2024 11:09:48 GMT
• biopharma layoff tracker 2024: oncternal, biosense webster, charles river laboratories and more cut staff BioSpace Mon, 15 Jul 2024 11:09:48 GMT
• oncternal announces enrollment completed and dosing initiated for sixth dose cohort of phase 1/2 study of onct-534 for the treatme... Stock Titan Mon, 15 Jul 2024 07:00:00 GMT
• oncternal completes enrollment, dosing in phase 1/2 study of onct-534 TipRanks Mon, 15 Jul 2024 07:00:00 GMT
• oncternal therapeutics (nasdaq:onct) earns hold rating from analysts at stocknews.com Defense World Sun, 14 Jul 2024 08:18:20 GMT
• stocknews.com initiates coverage on oncternal therapeutics (nasdaq:onct) American Banking and Market News Sun, 14 Jul 2024 05:18:56 GMT
• oncternal therapeutics to present in jonestrading healthcare summit GlobeNewswire Thu, 11 Jul 2024 07:00:00 GMT
• metastatic prostate cancer clinical trial pipeline insights featuring 75+ companies | delveinsight GlobeNewswire Wed, 10 Jul 2024 07:00:00 GMT
• dr. basralian on the current state of focal therapy in prostate cancer Urology Times Wed, 10 Jul 2024 07:00:00 GMT
• oncternal therapeutics (nasdaq:onct) now covered by stocknews.com Defense World Sat, 06 Jul 2024 05:29:49 GMT
• oncternal therapeutics provides business update and announces fourth quarter and full year 2023 financial results GlobeNewswire Wed, 03 Jul 2024 07:00:00 GMT
• oncternal therapeutics to participate in oppenheimer 34th annual healthcare life sciences conference Quantisnow Tue, 02 Jul 2024 16:35:21 GMT
• open-label, multicenter, phase i/ii, first-in-human trial of tk216: a first-generation ews::fli1 fusion protein antagonist in ewin... ASCO Publications Tue, 02 Jul 2024 07:00:00 GMT
• oncternal therapeutics | biotechnology | the pharmaletter The Pharma Letter Sat, 29 Jun 2024 11:58:51 GMT
• stocknews.com begins coverage on oncternal therapeutics (nasdaq:onct) Defense World Fri, 28 Jun 2024 07:15:12 GMT
• oncternal (onct) down on restructuring plan to extend runway Yahoo Singapore News Thu, 27 Jun 2024 03:49:46 GMT
• stocknews.com initiates coverage on oncternal therapeutics (nasdaq:onct) Defense World Thu, 20 Jun 2024 05:25:47 GMT
• we think some shareholders may hesitate to increase oncternal therapeutics, inc.'s (nasdaq:onct) ceo compensation Simply Wall St Fri, 14 Jun 2024 07:00:00 GMT
• oncternal therapeutics (nasdaq:onct) now covered by analysts at stocknews.com Defense World Wed, 12 Jun 2024 08:15:17 GMT
• oncternal therapeutics (nasdaq:onct) receives “buy” rating from hc wainwright Defense World Sat, 01 Jun 2024 07:00:00 GMT
• oncternal: enrollment complete in 1/2 study of onct-534 to treat r/r pca - tipranks.com TipRanks Fri, 31 May 2024 21:05:08 GMT
• oncternal announces enrollment completed and dosing initiated for fifth dose cohort of phase 1/2 study of onct-534 for the treatme... Yahoo Finance Thu, 30 May 2024 07:00:00 GMT
• stocknews.com begins coverage on oncternal therapeutics (nasdaq:onct) Defense World Mon, 27 May 2024 05:25:38 GMT
• onct stock earnings: oncternal therapeutics misses eps, beats revenue for q4 2023 MSN Fri, 17 May 2024 11:21:35 GMT
• b-cell lymphoma pipeline assessment, 2024 updates: fda, ema, and pmda approvals, emerging drugs, clinical ... openPR Fri, 17 May 2024 07:00:00 GMT
• oncternal therapeutics (onct) soars 8.4%: is further upside left in the stock? Yahoo Lifestyle UK Thu, 16 May 2024 10:11:42 GMT
• how the (onct) price action is used to our advantage Stock Traders Daily Thu, 16 May 2024 08:10:00 GMT
• oncternal therapeutics, inc. to post q2 2024 earnings of ($3.15) per share, hc wainwright forecasts (nasdaq:onct) Defense World Thu, 16 May 2024 05:50:08 GMT
• oncternal therapeutics first quarter 2023 earnings: revenues beat expectations, eps in line Yahoo Canada Shine On Wed, 15 May 2024 10:38:51 GMT
• oncternal therapeutics, inc. (nasdaq:onct) to post q1 2025 earnings of ($2.42) per share, hc wainwright forecasts Defense World Wed, 15 May 2024 09:26:22 GMT
• oncternal therapeutics (nasdaq:onct) price target cut to $19.00 Defense World Wed, 15 May 2024 06:55:20 GMT
• implied volatility surging for oncternal therapeutics (onct) stock options Yahoo News UK Sun, 12 May 2024 14:26:39 GMT
• oncternal therapeutics (nasdaq:onct) now covered by stocknews.com Defense World Sat, 11 May 2024 18:16:23 GMT
• oncternal therapeutics (onct) stock forecast and price target 2024 MarketBeat Sat, 11 May 2024 13:32:13 GMT
• earnings call: oncternal reports q1 results and clinical progress Investing.com India Sat, 11 May 2024 07:00:00 GMT
• oncternal therapeutics, inc. (nasdaq:onct) q1 2024 earnings call transcript Yahoo Finance Fri, 10 May 2024 07:00:00 GMT
• oncternal therapeutics provides business update and announces first quarter 2024 financial results Investing.com India Fri, 10 May 2024 07:00:00 GMT
• earnings call: oncternal reports q1 results and clinical progress by investing.com Investing.com Fri, 10 May 2024 07:00:00 GMT
• onct stock earnings: oncternal therapeutics beats eps, beats revenue for q1 2024 MSN Fri, 10 May 2024 02:14:54 GMT
• oncternal therapeutics (onct) reports q1 loss, tops revenue estimates Zacks Investment Research Fri, 10 May 2024 00:17:17 GMT
• oncternal therapeutics: q1 earnings snapshot | state and regional | santamariatimes.com Santa Maria Times Thu, 09 May 2024 20:16:41 GMT
• oncternal therapeutics: q1 earnings snapshot | news | bakersfield.com The Bakersfield Californian Thu, 09 May 2024 20:16:41 GMT
• oncternal therapeutics reports q1 eps ($2.83), consensus ($2.88) - tipranks.com TipRanks Thu, 09 May 2024 19:52:30 GMT
• oncternal therapeutics provides business update and announces first quarter 2024 financial results Yahoo Finance Thu, 09 May 2024 07:00:00 GMT
• oncternal therapeutics, inc. (onct) q1 2024 earnings call transcript Seeking Alpha Thu, 09 May 2024 07:00:00 GMT
• oncternal therapeutics (onct) reports q1 loss, tops revenue estimates Zacks Investment Research Thu, 09 May 2024 07:00:00 GMT
• all you need to know about oncternal therapeutics (onct) rating upgrade to buy Yahoo Finance UK Wed, 08 May 2024 16:00:10 GMT
• oncternal therapeutics (onct) scheduled to post earnings on thursday Defense World Wed, 08 May 2024 13:30:14 GMT
• chronic lymphocytic leukemia market is projected to grow at a moderate growth rate during the forecast period openPR Mon, 06 May 2024 23:22:00 GMT
• darolutamide use is routine in both doublets and triplet therapies in mhspc OncLive Sun, 05 May 2024 07:00:00 GMT
• oncternal therapeutics (nasdaq:onct) coverage initiated at stocknews.com Defense World Fri, 03 May 2024 06:23:01 GMT
• oncternal therapeutics to provide business update and report first quarter 2024 financial results ForexTV.com Fri, 03 May 2024 02:16:17 GMT
• oncternal therapeutics first quarter 2023 earnings: revenues beat expectations, eps in line Yahoo Movies UK Thu, 02 May 2024 08:45:23 GMT
• oncternal therapeutics to provide business update and report first quarter 2024 financial results Yahoo Finance Thu, 02 May 2024 07:00:00 GMT
• oncternal therapeutics (onct) expected to beat earnings estimates: what to know ahead of q4 release Yahoo Singapore News Thu, 02 May 2024 06:36:14 GMT
• oncternal therapeutics reports inducement award under nasdaq listing rule 5635(c)(4) - may 1, 2024 BioSpace Wed, 01 May 2024 07:00:00 GMT
• stocknews.com initiates coverage on oncternal therapeutics (nasdaq:onct) Defense World Thu, 25 Apr 2024 07:00:00 GMT
• oncternal therapeutics (onct) may report negative earnings: know the trend ahead of q1 release Yahoo Finance Thu, 25 Apr 2024 07:00:00 GMT
• oncternal announces first patient dosed in fourth cohort of study of onct-534 - tipranks.com TipRanks Fri, 19 Apr 2024 14:16:26 GMT
• trial of onct-534 in mcrpc progresses to higher dose level Urology Times Fri, 19 Apr 2024 07:00:00 GMT
• q1 2024 earnings forecast for oncternal therapeutics, inc. issued by hc wainwright (nasdaq:onct) Defense World Thu, 18 Apr 2024 09:47:35 GMT
• oncternal announces first patient dosed in fourth cohort of phase 1/2 study of onct-534 for the treatment of r/r ... Yahoo Finance Thu, 18 Apr 2024 07:00:00 GMT
• oncternal therapeutics (nasdaq:onct) receives new coverage from analysts at stocknews.com Defense World Wed, 17 Apr 2024 06:16:38 GMT
• hc wainwright trims oncternal therapeutics (nasdaq:onct) target price to $28.00 Defense World Tue, 16 Apr 2024 08:47:04 GMT
• chronic lymphocytic leukemia market anticipated to expand by 2032, as projected by delveinsight openPR Tue, 16 Apr 2024 07:00:00 GMT
• oncternal shares price target cut by h.c. wainwright on q4 earnings miss by investing.com Investing.com Mon, 15 Apr 2024 07:00:00 GMT
• how a multidisciplinary approach resulted in salvage therapy for prostate cancer guideline Urology Times Sun, 14 Apr 2024 10:18:30 GMT
• robert james wills purchases 3086 shares of oncternal therapeutics, inc. (nasdaq:onct) stock Defense World Fri, 12 Apr 2024 09:52:24 GMT
• dr. morgan discusses guideline for salvage therapy in prostate cancer Urology Times Thu, 11 Apr 2024 07:00:00 GMT
• morgan stanley: is tesla finally getting its mojo back? by investing.com Investing.com India Thu, 11 Apr 2024 07:00:00 GMT
• oncternal therapeutics director buys $27.7k of company stock by investing.com Investing.com India Thu, 11 Apr 2024 07:00:00 GMT
• oncternal therapeutics director buys $27.7k of company stock by investing.com Investing.com Wed, 10 Apr 2024 07:00:00 GMT
• oncternal therapeutics, inc. (nasdaq:onct) director robert james wills purchases 6914 shares Defense World Tue, 02 Apr 2024 08:29:45 GMT
• insiders buying westlake chemical partners and 2 other stocks - oncternal therapeutics (nasdaq:onct), sow Benzinga Tue, 02 Apr 2024 07:00:00 GMT
• oncternal therapeutics director acquires 6,914 shares — tradingview news TradingView Mon, 01 Apr 2024 23:31:33 GMT
• oncternal therapeutics director buys $58.6k in company stock Investing.com Mon, 01 Apr 2024 07:00:00 GMT
• juniper networks evp cfo kenneth miller sells shares worth over $2.8m by investing.com Investing.com Mon, 01 Apr 2024 07:00:00 GMT
• oncternal therapeutics, inc. (nasdaq:onct) given consensus rating of “hold” by analysts Defense World Sun, 31 Mar 2024 06:36:19 GMT
• oncternal therapeutics (nasdaq:onct) stock price up 9.8% Defense World Sat, 30 Mar 2024 05:59:21 GMT
• dr olivares on the use of focal therapy in localized prostate cancer OncLive Tue, 26 Mar 2024 07:00:00 GMT
• oncternal therapeutics (onct) reports q1 loss, tops revenue estimates Yahoo Movies UK Wed, 20 Mar 2024 07:00:00 GMT
• oncternal participating in virtual fireside chat with key GlobeNewswire Fri, 15 Mar 2024 07:00:00 GMT
• oncternal therapeutics full year 2023 earnings: revenues beat expectations, eps in line Yahoo Finance Sun, 10 Mar 2024 08:00:00 GMT
• oncternal therapeutics (nasdaq:onct) upgraded to “hold” by stocknews.com Defense World Sun, 10 Mar 2024 07:49:40 GMT
Oncternal Therapeutics, Inc(NASDAQ:ONCT) 
Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical need. Its pipeline includes cirmtuzumab, an investigational monoclonal antibody that is being evaluated in a Phase 1/2 clinical trial in ...
Website: http://www.oncternal.com
Founded: 1997
Full Time Employees: 11
CEO: James B. Breitmeyer
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends